Schizophrenia

...ba href=/schizophrenia/a/b sitting on a bare mattress soaked in her urine and another woman with psychotic delusions living in a place with rats and roaches.

"We have to inspect, to close down, to monitor," said Soika.

He urged everyone to call Walker and Barrett to insist that the county and city set aside 100 housing units a year for the next five years specifically for people who have mental illness who are living in poverty.

A recent study by the U.S.

Department of Housing and Urban Development says that Milwaukee County needs 28,000 more housing units to satisfy the demand.

"It's not complicated," Soika said.

"The way to solve homelessness is to put people in a house." In the past 25 years, the number of people in Milwaukee living in crowded conditions has increased by 14,000, or 76%, he said.

From the March 24, 2006 editions of the Milwaukee Journal Sentinel Have an opinion on this story?

Write a letter to the editor or start an online forum.Subscribe today and receive 4 weeks free!

Sign up now.

BACK TO TOP News Privacy Policy Journal Sentinel Inc.

is a subsidiary of Journal Communications.

...

...ba href=/schizophrenia/a/b.

About Parkinson's Disease Parkinson's disease is a chronic, progressive neurological disorder that results from the degeneration of neurons in a region of the brain that controls movement.

It is marked by a number of debilitating symptoms, including tremors, limb stiffness, slowness of movements, and difficulties with posture and balance.

According to the American Parkinson's Disease Association, over 1.5 million people in the United States suffer from Parkinson's disease.

Patients with Parkinson's disease are currently treated with dopamine replacement therapies and the use of these agents frequently results in a range of drug-induced side effects, including neuropsychiatric abnormalities such as psychotic symptoms as well as uncontrollable and excessive movements of the limbs referred to as dyskinesias.

There have been numerous attempts to use existing antipsychotic drugs to treat the neuropsychiatric abnormalities caused by the treatment of Parkinson's disease.

Because antipsychotic agents worsen the pre-existing brain dopamine deficit and often produce disabling side effects, these drugs are generally not well tolerated by patients with Parkinson's disease.

Currently, there is a large unmet medical need for therapies that will effectively control or eliminate the side effects that result from the use of dopamine replacement therapies, without impairing motor function in these patients.

About ACADIA Pharmaceuticals ACADIA Pharmaceuticals is a biopharmace...

...ba href=/schizophrenia/a/b in Westervelt's family, but the prosecutor says it's only a matter of time before doctors find him competent.

All content © Copyright 2000 - 2006 WorldNow and WLNS.

All Rights Reserved.For more information on this site, please read our Privacy Policy and Terms of Service.

...